Expert Ratings For Innovid


Across the recent three months, 5 analysts have shared their insights on Innovid CTV, expressing a variety of opinions spanning from bullish to bearish.

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 2 1 2 0 0
Last 30D 1 0 0 0 0
1M Ago 0 1 1 0 0
2M Ago 0 0 0 0 0
3M Ago 1 0 1 0 0

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $2.39, a high estimate of $3.00, and a low estimate of $1.60. Marking an increase of 34.27%, the current average surpasses the previous average price target of $1.78.

Breaking Down Analyst Ratings: A Detailed Examination

The perception of Innovid by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Laura Martin Needham Raises Buy $3.00 $2.25
Brian Nowak Morgan Stanley Raises Equal-Weight $2.10 $1.60
Andrew Boone JMP Securities Maintains Market Outperform $3.00 -
Brian Nowak Morgan Stanley Raises Equal-Weight $1.60 $1.50
Laura Martin Needham Maintains Buy $2.25 -

Key Insights:

  • Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Innovid. This offers insight into analysts' perspectives on the current state of the company.
  • Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Innovid compared to the broader market.
  • Price Targets: Analysts predict movements in price targets, offering estimates for Innovid's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.

Capture valuable insights into Innovid's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.

Stay up to date on Innovid analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

Delving into Innovid's Background

Innovid Corp is a software platform that provides ad serving, measurement and optimization creative services for the creation, delivery, and measurement of TV ads across connected TV, mobile TV and desktop TV environments to advertisers, publishers and media agencies. It is engaged in ad serving, measurement and creative services. It operates in U.S., Canada, EMEA, APAC and LATAM, out of which it derives maximum revenue from U.S.

Innovid: Financial Performance Dissected

Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.

Positive Revenue Trend: Examining Innovid's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 14.6% as of 31 December, 2023, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Communication Services sector.

Net Margin: Innovid's net margin is impressive, surpassing industry averages. With a net margin of -4.29%, the company demonstrates strong profitability and effective cost management.

Return on Equity (ROE): Innovid's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of -0.85%, the company showcases efficient use of equity capital and strong financial health.

Return on Assets (ROA): Innovid's ROA stands out, surpassing industry averages. With an impressive ROA of -0.67%, the company demonstrates effective utilization of assets and strong financial performance.

Debt Management: Innovid's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.11.

Analyst Ratings: What Are They?

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.

Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.

Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Price Target
Posted In: Analyst RatingsBZI-AAR
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!